The value of neutrophil-to-lymphocyte ratio in predicting severity of coronary involvement and long-term outcome of percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis

被引：0
作者：
Farzad Shahsanaei
Shahin Abbaszadeh
Soudabeh Behrooj
Nima Rahimi Petrudi
Bahareh Ramezani
机构：
[1] Hormozgan University of Medical Sciences,Cardiovascular Research Center
来源：
The Egyptian Heart Journal | / 76卷
关键词：
Acute coronary syndrome; Major adverse cardiac event; Neutrophil-to-lymphocyte ratio; Percutaneous coronary intervention; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease A protocol for systematic review and meta-analysis [J].
Liu, Shengxiang ;
Yang, Guokang ;
Huang, Yupeng ;
Zhang, Cheng ;
Jin, Hongyan .
MEDICINE, 2021, 100 (01) :E24114
[42]   Clinical Effect of Maixuekang Capsule on Long-Term Prognosis in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention [J].
Ge Chang-jiang ;
Yuan Fei ;
Feng Li-xia ;
Lv Shu-zheng ;
Liu Hong ;
Song Xian-tao ;
Chen Xin ;
Huo Yong .
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2014, 20 (02) :88-93
[43]   Hybrid coronary revascularization versus percutaneous coronary intervention: A systematic review and meta-analysis [J].
Van den Eynde, Jef ;
Sa, Michel Pompeu ;
De Groote, Senne ;
Amabile, Andrea ;
Sicouri, Serge ;
Ramlawi, Basel ;
Torregrossa, Gianluca ;
Oosterlinck, Wouter .
IJC HEART & VASCULATURE, 2021, 37
[44]   Predictors of Long-Term Survival in Acute Coronary Syndrome Patients With Left Ventricular Dysfunction After Percutaneous Coronary Intervention [J].
Lee, Doo Hwan ;
Jeong, Myung Ho ;
Rhee, Jung Ae ;
Choi, Jin Su ;
Lee, Ki Hong ;
Lee, Min Goo ;
Sim, Doo Sun ;
Park, Keun-Ho ;
Yoon, Nam Sik ;
Yoon, Hyun Ju ;
Kim, Kye Hun ;
Park, Hyung Wook ;
Hong, Young Joon ;
Kim, Ju Han ;
Ahn, Youngkeun ;
Cho, Jeong Gwan ;
Park, Jong Chun ;
Kang, Jung Chaee .
KOREAN CIRCULATION JOURNAL, 2012, 42 (10) :692-697
[45]   Combination of D-dimer level and neutrophil to lymphocyte ratio predicts long-term clinical outcomes in acute coronary syndrome after intervention [J].
Gu, Ling-Feng ;
Gu, Jie ;
Wang, Si-Bo ;
Wang, Hao ;
Wang, Ya-Xin ;
Xue, Yuan ;
Wei, Tian-Wen ;
Sun, Jia-Teng ;
Lian, Xiao-Qing ;
Liu, Jia-Bao ;
Jia, En-Zhi ;
Wang, Lian-Sheng .
CARDIOLOGY JOURNAL, 2023, 30 (04) :576-586
[46]   The added value of coronary CTA in chronic total occlusion percutaneous coronary intervention: a systematic review and meta-analysis [J].
Liang, Shichu ;
Bai, Yanlin ;
Zhang, Jing ;
Wang, Aijie ;
Li, Jing ;
Diao, Kaiyue ;
He, Yong .
EUROPEAN RADIOLOGY, 2024, 34 (06) :4041-4052
[47]   Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: A systematic review and meta-analysis [J].
Zhang, Junyan ;
Chen, Zhongxiu ;
Wang, Duolao ;
Li, Chen ;
Luo, Fangbo ;
He, Yong .
CARDIOLOGY JOURNAL, 2024, 31 (02) :309-320
[48]   Efficacy and Safety of Low-Dose Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis [J].
Yuttana Wongsalap ;
Supakorn Ungsriwong ;
Wanalee Kumtep ;
Surasak Saokaew ;
Vichai Senthong ;
Kirati Kengkla .
Cardiovascular Drugs and Therapy, 2022, 36 :991-1000
[49]   Predictive value of lymphocyte-to-monocyte ratio in patients with contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome [J].
Karauzum, Irem ;
Karauzum, Kurtulus ;
Acar, Burak ;
Hanci, Kaan ;
Bildirici, Halil Ibrahim Ulas ;
Kilic, Teoman ;
Ural, Ertan .
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2021, 9 (02) :123-130
[50]   Efficacy and Safety of Low-Dose Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis [J].
Wongsalap, Yuttana ;
Ungsriwong, Supakorn ;
Kumtep, Wanalee ;
Saokaew, Surasak ;
Senthong, Vichai ;
Kengkla, Kirati .
CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) :991-1000
12345